Prophylaxis With Ganciclovir Improves Graft Survival in Renal Allograft Recipients
NCT00373165
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
150
Enrollment
OTHER
Sponsor class
Conditions
DNA Virus Infection
Herpesviridae Infections
Cytomegalovirus Infection
Interventions
DRUG:
Ganciclovir
Sponsor
Lower Saxony Center for Nephrology